We are live on ! Find out more
SPPI

Spectrum Pharmaceuticals Inc

Delisted

SPPI was delisted on the 31st of July, 2023.

173 hedge funds and large institutions have $881M invested in Spectrum Pharmaceuticals Inc in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 76 increasing their positions, 38 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 76 | Existing positions reduced: 38

16% more capital invested

Capital invested by funds: $757M → $881M (+$123M)

2% less funds holding

Funds holding: 176173 (-3)

14% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 22

56% less call options, than puts

Call options by funds: $727K | Put options by funds: $1.66M

Holders
173
Holders Change
-3
Holders Change %
-1.7%
% of All Funds
3.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
76
Reduced
38
Closed
22
Calls
$727K
Puts
$1.66M
Net Calls
-$930K
Net Calls Change
-$336K
Name Holding Trade Value Shares
Change
Change in
Stake
PCM
151
Prelude Capital Management
New York
$8K +$236 +22 +3%
Daiwa Securities Group
152
Daiwa Securities Group
Japan
$8K +$1.61K +150 +27%
FHA
153
Flagship Harbor Advisors
Massachusetts
$6K
FDCDDQ
154
Federation des caisses Desjardins du Quebec
Quebec, Canada
$5.34K
Walleye Trading
155
Walleye Trading
New York
$5K -$89K -8,311 -95%
Nisa Investment Advisors
156
Nisa Investment Advisors
Missouri
$5K
PHK
157
Point72 Hong Kong
Hong Kong
$5K +$4.67K +436 New
VCM
158
Versant Capital Management
Arizona
$4K -$13.8K -1,284 -74%
FPFS
159
First Personal Financial Services
North Carolina
$4K
GAM
160
Gemmer Asset Management
California
$3K
TWA
161
TCI Wealth Advisors
Arizona
$3K
MAM
162
Meeder Asset Management
Ohio
$2K -$6.33K -591 -79%
TRCT
163
Tower Research Capital (TRC)
New York
$2K +$2.14K +200 New
WCG
164
Weaver Consulting Group
California
$2K +$2.14K +200 New
US Bancorp
165
US Bancorp
Minnesota
$1K -$12.3K -1,151 -90%
WAM
166
Wolverine Asset Management
Illinois
$1K
PFBT
167
Parkside Financial Bank & Trust
Missouri
$1K +$300 +28 +32%
CAM
168
Cresset Asset Management
Illinois
$1K +$942 +88 New
GT
169
Glenmede Trust
Pennsylvania
$3 -$9.32K -870 -71%
CCM
170
Consonance Capital Management
New York
-$26M -2,969,027 Closed
O
171
OrbiMed
New York
-$19.8M -2,265,500 Closed
Point72 Asset Management
172
Point72 Asset Management
Connecticut
-$4.72M -539,200 Closed
JGC
173
J. Goldman & Co
New York
-$2.34M -267,801 Closed
Susquehanna International Group
174
Susquehanna International Group
Pennsylvania
-$776K -72,448 Closed
PVAM
175
Pacific View Asset Management
California
-$605K -69,143 Closed

SPPI Hedge Fund Activity: Q1 2019 in Review

173 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2019, worth a combined $881M — up 16% from $757M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of SPPI and 19 opened new positions — a net loss of 3 holders — while 38 trimmed existing stakes and 76 added.

The largest buyer was Millennium Management, adding an estimated $9.11M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $26M sold.

  • 173 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2019, down from 176 in Q4 2018.
  • Funds reported $881M of Spectrum Pharmaceuticals Inc stock for Q1 2019, up 16% quarter-over-quarter.
  • 19 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2019 and 22 closed out, a net change of -3 holders.
  • The largest Spectrum Pharmaceuticals Inc buyer in Q1 2019 was Millennium Management, an estimated $9.11M added.
  • The largest Spectrum Pharmaceuticals Inc seller in Q1 2019 was Consonance Capital Management, an estimated $26M sold.

Based on aggregated 13F filings for Q1 2019.